References
Original article
Montalban, X. et al. Efficacy and safety of evobrutinib versus teriflunomide in relapsing multiple sclerosis: results from the phase 3 evolution RMS 1 and 2 Trials. ACTRIMS Forum https://www.abstractsonline.com/pp8/#!/20258/presentation/696 (2024)
Related article
Krämer, J. et al. Bruton tyrosine kinase inhibitors for multiple sclerosis. Nat. Rev. Neurol. 19, 289–304 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wood, H. BTK inhibitor falters in multiple sclerosis trials. Nat Rev Neurol 20, 255 (2024). https://doi.org/10.1038/s41582-024-00958-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-024-00958-8
- Springer Nature Limited